Barclays »

Janux Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.9M 174k 45.43
2024-06-30 $1.2M 29k 41.88
2024-03-31 $584k 16k 37.68
2023-12-31 $511k 48k 10.71
2023-09-30 $181k 18k 10.10
2023-06-30 $65k 5.5k 11.86
2023-03-31 $108k 8.9k 12.17
2022-12-31 $61k 4.6k 13.24
2022-09-30 $10k 728 13.74
2022-06-30 $11k 860 12.79
2022-03-31 $42k 2.9k 14.25